Marker Therapeutics Ownership | Who Owns Marker Therapeutics?


OverviewRevenueFinancialsChart

Marker Therapeutics Ownership Summary


Marker Therapeutics is owned by 0.79% institutional investors, 12.20% insiders, and 87.01% retail investors. Ar asset management is the largest institutional shareholder, holding 0.79% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.72% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMarker Therapeutics0.79%12.20%87.01%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ar asset management70.70K0.79%$384.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ar asset management70.70K0.09%$384.00K

Top Buyers

HolderShares% AssetsChange
Ar asset management70.70K0.09%-

Top Sellers

HolderShares% AssetsChange
Ar asset management70.70K0.09%-

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-70,700--125.86%----
Mar 31, 20241-70,700--123.79%----
Dec 31, 20231-70,700--124.07%--100.00%--
Sep 30, 20231-70,70073.71%-368.91%1---
Jun 30, 20231-50.00%40,700-88.53%-2.82%--100.00%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv153.47K1.72%-
Vanguard Institutional Extnd Mkt Idx Tr87.14K0.98%-
Fidelity Extended Market Index40.84K0.46%3.17K
WEALTHGATE Biotech Aggressive Fund I25.44K0.29%-
iShares Micro-Cap ETF16.58K0.19%-
DFA US Small Cap I15.90K0.18%-
WEALTHGATE Biotech Fund Inst9.51K0.11%-
Fidelity Series Total Market Index9.02K0.10%-
Fidelity Total Market Index8.95K0.10%-
NT Ext Equity Mkt Idx Fd - NL5.80K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 16, 2021Eansor Norman David-Buy$249.99K
May 18, 2021Wasserman Frederick Gerald-Buy$24.10K
Mar 16, 2021Walker Paul Edward-Buy$10.00M
Mar 16, 2021Sonsini Peter W.-Buy$10.00M
Mar 16, 2021SANDELL SCOTT D-Buy$10.00M

Insider Transactions Trends


DateBuySell
2023 Q2--
2023 Q1--
2022 Q2--
2022 Q1--
2021 Q4--

MRKR Ownership FAQ


Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 0.79%, followed by 12.20% insiders and 87.01% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 44.97%, which Marker Therapeutics falls below.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Ar asset management is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.09% of its assets in 70.7K Marker Therapeutics shares, valued at 384K$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.72% of its total shares outstanding invested in 153.47K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools